Steady Cure in Progress:

DIVISLAB

Shows Signs of Revival

appears to be stabilising after the recent decline, with prices holding firmly above a key support zone. The stock is forming a short-term base with reduced selling pressure, indicating potential accumulation. Volume has cooled off, suggesting that aggressive distribution is behind. A sustained move above the immediate consolidation range can trigger renewed upside momentum, keeping the near-term bias positively inclined while support remains intact.